585 related articles for article (PubMed ID: 33373432)
1. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
Massey W; Brown JM
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
[TBL] [Abstract][Full Text] [Related]
2. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
3. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
[TBL] [Abstract][Full Text] [Related]
5. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
Wu J; Yang K; Fan H; Wei M; Xiong Q
Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
Agus A; Clément K; Sokol H
Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host-Microbe Interplay.
Liu Y; Hou Y; Wang G; Zheng X; Hao H
Trends Endocrinol Metab; 2020 Nov; 31(11):818-834. PubMed ID: 32284282
[TBL] [Abstract][Full Text] [Related]
10. Micronutrients impact the gut microbiota and blood glucose.
Barra NG; Anhê FF; Cavallari JF; Singh AM; Chan DY; Schertzer JD
J Endocrinol; 2021 Jul; 250(2):R1-R21. PubMed ID: 34165440
[TBL] [Abstract][Full Text] [Related]
11. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
[TBL] [Abstract][Full Text] [Related]
12. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
[TBL] [Abstract][Full Text] [Related]
13. Postprandial gut microbiota-driven choline metabolism links dietary cues to adipose tissue dysfunction.
Schugar RC; Willard B; Wang Z; Brown JM
Adipocyte; 2018 Jan; 7(1):49-56. PubMed ID: 29172946
[TBL] [Abstract][Full Text] [Related]
14. Dietary Patterns Affect the Gut Microbiome-The Link to Risk of Cardiometabolic Diseases.
Tindall AM; Petersen KS; Kris-Etherton PM
J Nutr; 2018 Sep; 148(9):1402-1407. PubMed ID: 30184227
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease.
Makki K; Deehan EC; Walter J; Bäckhed F
Cell Host Microbe; 2018 Jun; 23(6):705-715. PubMed ID: 29902436
[TBL] [Abstract][Full Text] [Related]
16. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.
Brown JM; Hazen SL
Annu Rev Med; 2015; 66():343-59. PubMed ID: 25587655
[TBL] [Abstract][Full Text] [Related]
17. Microbial metabolites as modulators of host physiology.
Joyce SA; Clarke DJ
Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
[TBL] [Abstract][Full Text] [Related]
20. Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery.
Wang M; Li L; Chen Y; Lian G; Wang J; Zhang J; Shan K; Shang L; Tian F; Jing C
Obes Surg; 2021 Jan; 31(1):327-336. PubMed ID: 32974816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
